1. Home
  2. CALC vs UG Comparison

CALC vs UG Comparison

Compare CALC & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • UG
  • Stock Information
  • Founded
  • CALC 2011
  • UG 1942
  • Country
  • CALC United States
  • UG United States
  • Employees
  • CALC N/A
  • UG N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • UG Package Goods/Cosmetics
  • Sector
  • CALC Health Care
  • UG Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • UG Nasdaq
  • Market Cap
  • CALC 40.3M
  • UG 45.5M
  • IPO Year
  • CALC N/A
  • UG N/A
  • Fundamental
  • Price
  • CALC $2.76
  • UG $9.68
  • Analyst Decision
  • CALC Strong Buy
  • UG
  • Analyst Count
  • CALC 5
  • UG 0
  • Target Price
  • CALC $18.20
  • UG N/A
  • AVG Volume (30 Days)
  • CALC 71.7K
  • UG 12.4K
  • Earning Date
  • CALC 11-13-2024
  • UG 11-08-2024
  • Dividend Yield
  • CALC N/A
  • UG 6.20%
  • EPS Growth
  • CALC N/A
  • UG 38.11
  • EPS
  • CALC N/A
  • UG 0.76
  • Revenue
  • CALC N/A
  • UG $12,312,275.00
  • Revenue This Year
  • CALC N/A
  • UG N/A
  • Revenue Next Year
  • CALC N/A
  • UG N/A
  • P/E Ratio
  • CALC N/A
  • UG $12.76
  • Revenue Growth
  • CALC N/A
  • UG 11.51
  • 52 Week Low
  • CALC $2.05
  • UG $6.75
  • 52 Week High
  • CALC $8.38
  • UG $16.25
  • Technical
  • Relative Strength Index (RSI)
  • CALC 34.02
  • UG 37.62
  • Support Level
  • CALC $2.67
  • UG $9.50
  • Resistance Level
  • CALC $2.90
  • UG $9.97
  • Average True Range (ATR)
  • CALC 0.26
  • UG 0.27
  • MACD
  • CALC 0.00
  • UG 0.10
  • Stochastic Oscillator
  • CALC 50.35
  • UG 26.09

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: